Smoldering Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Smoldering Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: European Myeloma Network (EMN) Sample Project
A European Myeloma Network study evaluating treatment options for multiple myeloma and related plasma cell disorders is currently recruiting…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Registry for Adults With Plasma Cell Disorders (PCD's)
Clinical trial registry update for adults with plasma cell disorders indicating active recruitment. The study is sponsored by UNC Lineberger…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) [NA]
A clinical trial is evaluating a plant-based diet and dietary supplements in people with smoldering multiple myeloma or monoclonal gammopath…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program [NA]
This is a clinical trial update for a screening and patient navigation program aimed at early detection of multiple myeloma and related diso…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Screening for AL Amyloidosis in Smoldering Multiple Myeloma
This clinical trial update indicates ongoing recruitment for a study screening for AL amyloidosis in people with smoldering multiple myeloma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial (TG01/QS-21 vaccine) is evaluating a peptide vaccine with QS-21 adjuvant in high-risk smoldering multiple myeloma…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma [Phase 2]
Phase 2 clinical trial evaluating immunotherapy with isatuximab and iberdomide for high-risk smoldering multiple myeloma; currently recruiti…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: DARA RVD For High Risk SMM [Phase 2]
A Phase 2 trial investigates adding daratumumab to the RVD regimen for high-risk Smoldering multiple myeloma and multiple myeloma; the study…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Immuno-PRISM (PRecision Intervention Smoldering Myeloma) [Phase 2]
Phase 2 Immuno-PRISM trial evaluating a precision intervention for smoldering multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Whole Body MRI in Oncology
This clinical trial update describes a study evaluating whole-body MRI in oncology across multiple cancer types, currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma [NA]
A clinical trial update indicates a BCMA/CD3 bispecific antibody is being studied for high-risk smoldering multiple myeloma, with the trial …
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma [Phase 2]
A Phase 2 trial is evaluating Ciltacabtagene Autoleucel for high-risk smoldering multiple myeloma and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma [Phase 2]
Phase 2 clinical trial update evaluating Elranatamab in high-risk smoldering multiple myeloma. The study is currently recruiting and is spon…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating curcumin and piperine in patients under surveillance for monoclonal gammopathy, smoldering multiple myelom…